Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    Huntington's disease, Siena Biotech
Show Display Options
Rank Status Study
1 Completed A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
2 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington's Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
3 Completed A Phase II Safety and Tolerability Study With SEN0014196
Condition: Huntington's Disease
Interventions: Drug: SEN0014196;   Drug: Placebo
4 Completed Escalating Dose Study in Healthy Volunteers With SEN0014196
Condition: Huntington's Disease
Intervention: Drug: SEN0014196

Indicates status has not been verified in more than two years